CIK 0001840233 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Xilio Therapeutics, Inc.
Sign in to watch- Ticker
- XLO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851623397
- Phone
- 617-833-1027
- Business address
- 828 WINTER STREET, WALTHAM, MA, 02451
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- EFFECT Other Notice of Effectiveness
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Delisting notice
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 6 of 19 · 361 filings